Abstract
A prospective collection of newly diagnosed cases of grade IV glioma in Lombardia, Italy, was started in 2003. In the present report, data are shown on 349 adult patients recruited up to 2005. The clinical features, pattern of care and outcome are discussed, together with the main prognostic factors. Males were affected more frequently than women; median age at onset was 60. Overall, gross total tumour resection was performed in roughly 50% of the patients, and partial resection and biopsy in 25% each; only 5 patients did not undergo histology. Adjuvant radiotherapy was delivered to 89% and chemotherapy to 82% of patients. Median survival was of 54 weeks. Most patients received protracted therapy with antiepileptic drugs, despite absence of seizures; over the course of the study, the practice pattern tended to change, shifting to the use of non-enzyme-inducing anti-epileptic drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Salmaggi A, Riva M, Silvani A et al, for the Lombardia Neurooncology Group (2005) A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy. Neurol Sci 26:227–234
Filippini G, Falcone C, Boiardi A et al (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro-oncology 10:79–87
Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557–564
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Stewart LA (2002) Chemotherapy in adult high grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359:1011–1018
Rosenthal MA, Drummond KJ, Dally M (2006) Management of glioma in Victoria (1998–2000): retrospective cohort study. Med J Aus 184:270–273
Magrini SM, Ricardi U, Santoni R et al (2006) Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 65:788–799
Ammirati M, Vick N, Liao YL et al (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201–206
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198
Winger MJ, MacDonald DR, Cairncross JG (1989) Supratentorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487–493
Franklin CI (1992) Does the extent of surgery make a difference in high grade malignant astrocytoma? Australas Radiol 36:44–47
Gamburg ES, Regine WF, Patchell RA et al (2000) The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 48:1359–1362
Oberndorfer S, Piribauer M, Marosi C et al (2005) P450 enzyme-inducing and non enzyme-inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255–260
Jaeckle K, Ballman K, Uhm J et al (2004) Relationship of administration of enzyme-inducing anticonvulsants (EIAC) to survival in patients with glioblastoma: a North Central Cancer treatment Group (NCCTG) study. Neuro-oncol 6:376
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salmaggi, A., Silvani, A., Merli, R. et al. Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience. Neurol Sci 29, 77–83 (2008). https://doi.org/10.1007/s10072-008-0865-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-0865-x